Progyny Reports Strong 2025 Financial Results and Active Share Repurchase Program in Annual 10-K
PGNY sits 17% above its 52-week low of $17.977.
Summary
Progyny filed its annual 10-K, confirming strong 2025 financial results with increased revenue and profitability, an expanded gross margin, and significant share repurchases under a new $200 million program.
Key Events · Earnings and Guidance · PGNY
-
Strong 2025 Financial Performance Confirmed
Progyny reported a 10% increase in revenue to $1.29 billion, a 7.7% rise in net income to $58.5 million, and an 11.7% growth in Adjusted EBITDA to $222.1 million for the fiscal year ended December 31, 2025. Gross margin also expanded by 190 basis points to 23.6%.
-
Active Share Repurchase Program
The company authorized a new $200 million share repurchase program in November 2025. As of the filing date (February 27, 2026), Progyny has already repurchased $159.4 million worth of common stock under this program, with $116.4 million remaining available.
-
Enhanced Financial Flexibility with New Credit Facility
Progyny entered into a $200 million revolving credit facility on July 1, 2025, which remained undrawn as of the filing date, providing additional liquidity and financial flexibility.
-
COO Adopts 10b5-1 Trading Plan
Chief Operating Officer Melissa Cummings adopted a Rule 10b5-1 trading plan on December 19, 2025, to sell up to 24,062 shares of common stock by March 31, 2027. This is a routine, pre-planned sale.
Analysis · PGNY · Industrial Applications And Services
This 10-K filing confirms Progyny's robust financial performance for fiscal year 2025, building on the preliminary results announced in yesterday's 8-K. The report details significant growth in revenue, net income, and Adjusted EBITDA, alongside an impressive expansion in gross margin. The company's active share repurchase program, with $159.4 million already executed under a new $200 million authorization, signals strong capital return to shareholders and management's confidence in the company's valuation. The establishment of a new $200 million revolving credit facility further enhances financial flexibility. While the core earnings figures were previously disclosed, this comprehensive annual report provides crucial audited details, risk factors, and a deeper understanding of the company's strategic direction and financial health, making it highly important for investors.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PGNY was trading at $21.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $17.98 to $28.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.